Confounding and indication for treatment in evaluation of drug treatment for hypertension
BMJ
.
1997 Nov 1;315(7116):1151-4.
doi: 10.1136/bmj.315.7116.1151.
Authors
D E Grobbee
1
,
A W Hoes
Affiliation
1
Julius Centre for Patient Oriented Research, Utrecht University Medical School, Academic Hospital, Netherlands. d.e.grobbee@med.ruu.nl
PMID:
9374894
PMCID:
PMC2127725
DOI:
10.1136/bmj.315.7116.1151
No abstract available
Publication types
Review
MeSH terms
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Confounding Factors, Epidemiologic
Humans
Hypertension / drug therapy*
Substances
Antihypertensive Agents